What is Barinthus Biotherapeutics plc?
As of September 9, 2026, Barinthus Biotherapeutics plc was acquired by Clywedog Therapeutics, Inc.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
As of September 9, 2026, Barinthus Biotherapeutics plc was acquired by Clywedog Therapeutics, Inc. , in a reverse merger transaction. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 30.23M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.